CHICAGO (GenomeWeb News) – As members of The Cancer Genome Atlas continue to characterize tumors, those involved in the effort are also looking beyond an already large catalog of cancer-associated genomic glitches, considering additional cancer features for profiling as well as ways of applying data that are available already.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The NIH has issued a preliminary guidance for newborn dried blood spot research.

Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.